2022
DOI: 10.3390/biom12040590
|View full text |Cite
|
Sign up to set email alerts
|

Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban

Abstract: Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its pharmacokinetic variability and a narrow therapeutic index, the safe administration of the drug requires its therapeutic drug monitoring (TDM) in patients receiving the treatment. In this work, we present a label-free method for the TDM of edoxaban by surface enhanced Raman spectroscopy (SERS). The new method utilises the thiol chemistry of the drug t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 35 publications
(51 reference statements)
0
1
0
Order By: Relevance
“…The surface plasmon resonance sensor employing a DNA aptamer can measure the concentration of an antineoplastic drug, irinotecan, with a high selectivity in a range of 0.2–12.8 μM [ 6 ]. More excellent sensitivity is described in a surface-enhanced Raman spectroscopy method with a direct anticoagulant, edoxaban, (limit of quantification: 1 pM) [ 7 ]. An electrode based on CeBiO x nanofiber detects acetaminophen with a low detection limit of 0.2 μM [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…The surface plasmon resonance sensor employing a DNA aptamer can measure the concentration of an antineoplastic drug, irinotecan, with a high selectivity in a range of 0.2–12.8 μM [ 6 ]. More excellent sensitivity is described in a surface-enhanced Raman spectroscopy method with a direct anticoagulant, edoxaban, (limit of quantification: 1 pM) [ 7 ]. An electrode based on CeBiO x nanofiber detects acetaminophen with a low detection limit of 0.2 μM [ 8 ].…”
Section: Introductionmentioning
confidence: 99%